VeriMomeucalyptus globulus leaf extract é seguro durante a gravidez?
No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
Pregnancy-safe products containing eucalyptus globulus leaf extract
Related ingredients
Frequently asked questions
- eucalyptus globulus leaf extract é seguro durante a gravidez?
- No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
- eucalyptus globulus leaf extract é seguro durante a amamentação?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Systemic absorption of volatile constituents is possible after topical application, so low but measurable exposure to lactating parent is plausible; no data indicate transfer to breastmilk or harmful effects in breastfed infants (sources: PubChem, PubMed, absence of ECHA harmonised classification).
- eucalyptus globulus leaf extract é seguro para a pele do bebê?
- No specific data showing developmental or reproductive toxicity in infants from topical cosmetic use of the leaf extract and no harmonised CLP reproductive hazard. However, infant skin has higher permeability and eucalyptus materials (notably eucalyptus oil/1,8‑cineole) are reported in the literature to cause adverse effects in young children when ingested or used inappropriately; therefore dermal exposure is judged as moderate (adult exposure scored as low measurable, increased by +1 for infants). No infant‑specific mechanistic evidence of reproductive endocrine disruption was found (sources: PubMed reports of pediatric toxicity from eucalyptus oil ingestion, EWG entries; no ECHA Annex VI reproductive flags).
- Como o VeriMom pontua eucalyptus globulus leaf extract?
- O VeriMom pontua eucalyptus globulus leaf extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a eucalyptus globulus leaf extract na gravidez?
- Veja nossa lista curada de alternativas seguras a eucalyptus globulus leaf extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.